Towards targeting platelet storage lesion-related signaling pathways

Blood Transfusion

Volumn 8, Issue SUPPL. 3, 2010, Pages

  Schubert, Peter ^a   Devine, Dana V ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Blood platelets; Platelet storage lesion; Protein kinase; Proteomics; Signal transduction

Indexed keywords

PROTEIN KINASE; THROMBOCYTE CONCENTRATE;

HEMOSTASIS; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOSIS;

BLOOD PLATELETS; BLOOD PRESERVATION; HUMANS; PLATELET TRANSFUSION; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 78049364454     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2010.011S     Document Type: Review

References (37)

1. Mustard JF, Walker CB. The influence of blood collecting techniques on platelet numbers during blood storage. Br J Haematol 1957; 3: 50-4.
2. Mustard JF. A study of changes in platelets, antihaemophilic globulin, factor V and factor VII during blood collection and storage by different techniques. Br J Haematol 1957; 3: 202-14.
3. Murphy S, Gardner FH. Platelet storage at 22 degrees C; metabolic, morphologic, and functional studies. J Clin Invest 1971; 50: 370-7.
4. Shrivastava M. The platelet storage lesion. Transfus Apher Sci 2009; 50: 105-13.
5. Thon JN, Schubert P, Devine DV. Platelet storage lesion: a new understanding from a proteomic perspective. Transfus Med Rev 2008; 22: 268-79.
6. Cauwenberghs S, van Pampus E, Curvers J et al. Hemostatic and signaling functions of transfused platelets. Transfus Med Rev 2007; 21: 287-94.
7. Kaufman RM. Platelets: testing, dosing and the storage lesion-recent advances. Hematology Am Soc Hematol Educ Program 2006; 492-6.
8. Seghatchian J. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers. Transfus Apher Sci 2006; 34: 125-30. (Pubitemid 43220396)
9. Bode AP. Platelet activation may explain the storage lesion in platelet concentrates. Blood Cells 1990; 16: 109-25.
10. Rinder HM, Snyder EL. Activation of platelet concentrate during preparation and storage. Blood Cells 1992; 18: 445-56.
11. Bertolini F, Porretti L, Lauri E et al. Role of lactate in platelet storage lesion. Vox Sang 1993; 65: 194-8.
12. Ribeiro A, Swann JC, Berndt MC. Alterations of the level of glycoproteins Ib-IX and IIb-IIIain platelets stored at 22 degrees C. Thromb Res 1992; 66: 619-27.
13. Bergmeier W, Burger PC, Piffath CL et al. Metalloproteinase inhibitors improve recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood 2003; 102: 4229-35.
14. Maurer-Spurej E, Chipperfield K. Past and future approaches to assess the quality of platelets for transfusion. Transfus Med Rev 2007; 21: 295-306. (Pubitemid 47454557)
15. Holme S, Murphy S. Platelet storage at 22 degrees C for transfusion: interrelationship of platelet density and size, medium pH, and viability after in vivo infusion. J Lab Clin Med 1983; 101: 161-74.
16. Leach MF, AuBuchon JP. Effect of storage time on clinical efficacy of single-donor platelet units. Transfusion 1993; 33: 661-4.
17. Bode AP, Miller DT. Preservation of in vitro function of platelets stored in the presence of inhibitors of platelet activation and a specific inhibitor of thrombin. J Lab Clin Med 1988; 111: 118-24.
18. Sweeney JD, Blair AJ, Cheves TA et al. L-carnitine decreases glycolysis in liquid-stored platelets. Transfusion 2000; 40: 1313-9.
19. Holme S, Heaton WA, Courtright M. Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution. Br J Haematol 1987; 66: 233-8.
20. Rivera J, Lozano ML, Corral J et al. Quality assessment of platelet concentrates supplemented with second-messenger effectors. Transfusion 1999; 39: 135-43.
21. Diedrich B, Sandgren P, Jansson B. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution. Vox Sang 2008; 94: 96-102.
22. Gulliksson H. Platelet additive solutions: current status. Immunohematology 2007; 23: 14-9. (Pubitemid 46608791)
23. Zhang JG, Carter CJ, Devine DV et al. Comparison of a novel viscous platelet additive solution and plasma: preparation and in vitro storage parameters of buffy-coat-derived platelet concentrates. Vox Sang 2008; 94: 299-305.
24. Hoffmeister KM, Felbinger TW, Falet H et al. The clearance mechanism of chilled blood platelets. Cell 2003: 112: 87-97.
25. Hoffmeister KM, Josefsson EC, Isaac NA et al. Glycosylation restores survival of chilled blood platelets. Science 2003; 301: 1531-4.
26. Wandall HH, Hoffmeister KM, Sørensen AL et al. Galactosylation does not prevent the rapid clearance of long-term, 4 degrees C-stored platelets. Blood 2008; 111: 3249-56
27. Schubert P, Devine DV. Proteomics meets blood banking: Identification of protein targets for the improvement of platelet quality. J Proteomics 2010; 73: 436-444.
28. Thiele T, Steil L, Gebhard S et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007; 47: 1221-33.
29. Thon JN, Schubert P, Duguay M et al. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 2008; 48: 425-35.
30. García A, Prabhakar S, Hughan S et al. Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. Blood 2004; 103: 2088-95. (Pubitemid 38326224)
31. Schubert P, Thon JN, Walsh GM et al. A signaling pathway contributing to platelet storage lesion development: targeting PI3-kinase-dependent Rap1 activation slows storage-induced platelet deterioration. Transfusion 2009; 49: 1944-55.
32. Canault M, Duerschmied D, Brill A et al. p38 mitogen-activated protein kinase activation during platelet storage: consequences for platelet recovery and hemostatic function in vivo. Blood 2010 in press; DOI 10.1182/blood-2009-03- 211706
33. Solheim BG, Seghatchian J. The six questions of pathogen reduction technology: an overview of current opinions. Transfus Apher Sci 2008; 39: 51-7.
34. Picker SM, Steisel A, Gathof BS. Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study. Transfus Apher Sci 2009; 40: 79-85.
35. Lin L, Conlan MG, Tessman J et al. Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment. Transfusion 2005; 45: 1610-20.
36. Osselaer JC, Doyen C, Defoin L et al. Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use. Transfusion 2009; 49: 1412-22.
37. Mohr H, Steil L, Gravemann U et al. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion 2009; 49: 2612-24.